Olodaterol
Olodaterol
Olodaterol (/ˌoʊloʊˈdætərɒl/) is a long-acting beta-adrenoceptor agonist (LABA) that is used in the management of chronic obstructive pulmonary disease (COPD). It is marketed under the brand name Striverdi Respimat among others.
Etymology
The name "Olodaterol" is derived from parts of the words OLOng-acting DAily TERol. The suffix "-ol" is common in drugs that act on the adrenergic receptors, such as other LABAs.
Pharmacology
Olodaterol works by acting on the beta-2 adrenergic receptors in the lungs, causing the muscles in the airways to relax and thus improving airflow. It is a long-acting drug, meaning its effects last for 24 hours.
Usage
Olodaterol is used once daily for the long-term maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema.
Side Effects
Common side effects of Olodaterol include nasopharyngitis, upper respiratory tract infection, urinary tract infection, and sinusitis. Serious side effects may include worsening of breathing problems, fast or irregular heartbeat, and allergic reactions.
Related Terms
- Beta-adrenoceptor agonist
- Chronic obstructive pulmonary disease
- Chronic bronchitis
- Emphysema
- Nasopharyngitis
- Upper respiratory tract infection
- Urinary tract infection
- Sinusitis
External links
- Medical encyclopedia article on Olodaterol
- Wikipedia's article - Olodaterol
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski